EAU 2013 - Programme Book - YouMed

Monday
Monday, 18 March - EAU Programme
280 Programme Book
Abstract Session
12.15 - 13.45 BPH: Genes, biomarkers and beyond
Yellow Hall 1-2-3 - Level N1
Poster Session 74
Chairs: A. Bachmann, Basel (CH)
R.W.G. Watson, Dublin (IE)
Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes
in length, followed by 2 minutes for discussion. Extended presentations (*) are 4 minutes in length, followed
by 2 minutes for discussion.
899 Surface CD24 distinguishes undifferentiated from transit-amplifying cells in the basal layer of the human
prostate
N. Petkova, J. Hennenlotter, T. Todenhöfer, M. Sobiesiak, S. Aufderklamm, M. Scharpf, A. Stenzl, H. Bühring,
C. Schwentner (Tübingen, Germany)
* 900 Targeting both the dynamic and static components of LUTS/BPH using a soluble guanylate cyclase
stimulator compared to vardenafil: Preclinical evidences
D. Behr-Roussel, A. Oudot, S. Oger, D. Gorny, P. Sandner, J. Bernabé, L. Alexandre, F. Giuliano (Montigny-Le-
Bretonneux, France; Wuppertal, Germany)
901 SRD5A1 and SRD5A2 genes are associated with the treatment for benign prostatic hyperplasia with the
combination of 5α-reductase inhibitors and α-adrenergic-receptor antagonist
X. Gu, R. Na, W. Li, S. Tao, L. Tian, Z. Chen, Y. Jiao, J. Kang, S. Zheng, J. Xu, J. Sun, J. Qi (Shanghai, China;
Winston-Salem, United States of America)
902 Is the androgen receptor the link between inflammation and benign prostatic hyperplasia?
J.M. Willder, V.C. Walker, T. Christ, G.L. Halbert, C.P.C, Dick, C. Orange, T. Qayyum, P.G. Horgan,
M.A. Underwood, J. Edwards (Glasgow, United Kingdom)
903 Different high-fat diets induce overweight, insulin resistance and structural alterations on prostate rats
A. Furriel, P.C. Silva, P.C.G.P. Silva, D.B. De Souza, W.S. Costa, F.J.B. Sampaio, B.M. Gregório (Rio de Janeiro,
Brazil)
904 Is the cyclic AMP signaling a pivotal player in the control of prostate smooth muscle? A biochemical and
functional approach
S. Ückert, E.S. Waldkirch, G.T. Kedia, M.A. Kuczyk (Hanover, Germany)
* 905 Phosphorylation of the androgen receptor at serine 308 may link benign prostate enlargement to
cardiovascular disease
J.M. Willder, V. Walker, T. Christ, G.L. Halbert, C.P.C. Dick, C. Orange, P.G. Horgan, M.A. Underwood,
J. Edwards (Glasgow, United Kingdom)
906 Inhibition of EFS-, phenylephrine-, and thromboxane-induced contraction of human prostate smooth
muscle by the receptor antagonist, picotamide
M. Hennenberg, M. Miljak, F. Strittmatter, Y. Hocaoglu, B. Rutz, C. Füllhase, C.G. Stief, C. Gratzke (Munich,
Germany)
907 Noradrenaline induces binding of clathrin light chain A to alpha1A-adrenoceptors in the human prostate
M. Hennenberg, J. Miersch, B. Rutz, F. Strittmatter, S. Walther, R. Waidelich, A. Roosen, C.G. Stief, C. Gratzke
(Munich, Germany)